Cargando…

The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability

Interleukin-2 is central to the induction and maintenance of both natural (nT(reg)) and induced Foxp3-expressing regulatory T cells (iT(reg)). Thus, signals that modulate IL-2 availability may, in turn, also influence T(reg) homeostasis. Using global knockout and cell-specific knockout mouse models,...

Descripción completa

Detalles Bibliográficos
Autores principales: Geers, Bernd, Hagenstein, Julia, Endig, Jessica, Ulrich, Hanna, Fleig, Laura, Sprezyna, Paulina, Mikulec, Julita, Heukamp, Lukas, Tiegs, Gisa, Diehl, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454872/
https://www.ncbi.nlm.nih.gov/pubmed/36078047
http://dx.doi.org/10.3390/cells11172639
_version_ 1784785454858502144
author Geers, Bernd
Hagenstein, Julia
Endig, Jessica
Ulrich, Hanna
Fleig, Laura
Sprezyna, Paulina
Mikulec, Julita
Heukamp, Lukas
Tiegs, Gisa
Diehl, Linda
author_facet Geers, Bernd
Hagenstein, Julia
Endig, Jessica
Ulrich, Hanna
Fleig, Laura
Sprezyna, Paulina
Mikulec, Julita
Heukamp, Lukas
Tiegs, Gisa
Diehl, Linda
author_sort Geers, Bernd
collection PubMed
description Interleukin-2 is central to the induction and maintenance of both natural (nT(reg)) and induced Foxp3-expressing regulatory T cells (iT(reg)). Thus, signals that modulate IL-2 availability may, in turn, also influence T(reg) homeostasis. Using global knockout and cell-specific knockout mouse models, we evaluated the role of the small GTPase ADP-ribosylation factor 4d (Arl4d) in regulatory T-cell biology. We show that the expression of Arl4d in T cells restricts both IL-2 production and responsiveness to IL-2, as measured by the phosphorylation of STAT5. Arl4d-deficient CD4 T cells converted more efficiently into Foxp3(+) iT(reg) in vitro in the presence of αCD3ε and TGFβ, which was associated with their enhanced IL-2 secretion. As such, Arl4d(−/−) CD4 T cells induced significantly less colonic inflammation and lymphocytic infiltration in a model of transfer colitis. Thus, our data reveal a negative regulatory role for Arl4d in CD4 T-cell biology, limiting iT(reg) conversion via the restriction of IL-2 production, leading to reduced induction of T(reg) from conventional CD4 T cells.
format Online
Article
Text
id pubmed-9454872
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94548722022-09-09 The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability Geers, Bernd Hagenstein, Julia Endig, Jessica Ulrich, Hanna Fleig, Laura Sprezyna, Paulina Mikulec, Julita Heukamp, Lukas Tiegs, Gisa Diehl, Linda Cells Article Interleukin-2 is central to the induction and maintenance of both natural (nT(reg)) and induced Foxp3-expressing regulatory T cells (iT(reg)). Thus, signals that modulate IL-2 availability may, in turn, also influence T(reg) homeostasis. Using global knockout and cell-specific knockout mouse models, we evaluated the role of the small GTPase ADP-ribosylation factor 4d (Arl4d) in regulatory T-cell biology. We show that the expression of Arl4d in T cells restricts both IL-2 production and responsiveness to IL-2, as measured by the phosphorylation of STAT5. Arl4d-deficient CD4 T cells converted more efficiently into Foxp3(+) iT(reg) in vitro in the presence of αCD3ε and TGFβ, which was associated with their enhanced IL-2 secretion. As such, Arl4d(−/−) CD4 T cells induced significantly less colonic inflammation and lymphocytic infiltration in a model of transfer colitis. Thus, our data reveal a negative regulatory role for Arl4d in CD4 T-cell biology, limiting iT(reg) conversion via the restriction of IL-2 production, leading to reduced induction of T(reg) from conventional CD4 T cells. MDPI 2022-08-25 /pmc/articles/PMC9454872/ /pubmed/36078047 http://dx.doi.org/10.3390/cells11172639 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Geers, Bernd
Hagenstein, Julia
Endig, Jessica
Ulrich, Hanna
Fleig, Laura
Sprezyna, Paulina
Mikulec, Julita
Heukamp, Lukas
Tiegs, Gisa
Diehl, Linda
The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability
title The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability
title_full The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability
title_fullStr The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability
title_full_unstemmed The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability
title_short The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability
title_sort adp-ribosylation factor 4d restricts regulatory t-cell induction via control of il-2 availability
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454872/
https://www.ncbi.nlm.nih.gov/pubmed/36078047
http://dx.doi.org/10.3390/cells11172639
work_keys_str_mv AT geersbernd theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT hagensteinjulia theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT endigjessica theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT ulrichhanna theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT fleiglaura theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT sprezynapaulina theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT mikulecjulita theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT heukamplukas theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT tiegsgisa theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT diehllinda theadpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT geersbernd adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT hagensteinjulia adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT endigjessica adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT ulrichhanna adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT fleiglaura adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT sprezynapaulina adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT mikulecjulita adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT heukamplukas adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT tiegsgisa adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability
AT diehllinda adpribosylationfactor4drestrictsregulatorytcellinductionviacontrolofil2availability